NVS' Cosentyx fails to meet its primary goal in a phase III study for giant cell arteritis, despite favorable safety data.

AbbVie is testing its oral drug upadacitinib in a Phase 3 trial for patients with hidradenitis suppurativa (HS) who failed ...

Caring for your hidradenitis suppurativa (HS) wounds is an important part of promoting healing and preventing infection. Not sure where to begin? These wound care tips protect your skin from ...

Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

A new study published in the journal of PloS One found a significant link between smoking and a heightened risk of ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

A new study published in the Journal of American Medical Association showed that the prevalence of physical and mental comorbidities was greater in children with hidradenitis ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

Women with hidradenitis suppurativa perceived less respectful and effective communication from physicians than men.